ISHRAK OMAR 4

What Happened

• Ishrak Omar, a director of Amgen Inc., received an award of 106.193 shares (reported as code A) on May 5, 2026. The reported acquisition price is $0.00, indicating these are restricted stock units (RSUs) granted rather than a purchase.

Key Details

• Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (timely filing).
• Shares/units granted: 106.193; reported price: $0.00.
• Footnote: The grant includes 418 Dividend Equivalents (DEs) credited to the unvested RSUs under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and a qualifying dividend reinvestment plan. DEs are paid in shares on a one-for-one basis per the vesting schedule, with cash for any fractional share.
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context

• This is a company equity award (RSUs) to a director, not an open-market purchase or sale. Such grants are typically part of compensation and vest over time; they do not by themselves signal buying or selling intent.